rs2307058

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000158.4(GBE1):​c.1619-193C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,806 control chromosomes in the GnomAD database, including 6,523 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.29 ( 6523 hom., cov: 32)

Consequence

GBE1
NM_000158.4 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0520

Publications

7 publications found
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]
GBE1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to glycogen branching enzyme deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • adult polyglucosan body disease
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000158.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-81537288-G-A is Benign according to our data. Variant chr3-81537288-G-A is described in ClinVar as Benign. ClinVar VariationId is 1252926.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000158.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
NM_000158.4
MANE Select
c.1619-193C>T
intron
N/ANP_000149.4Q04446

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
ENST00000429644.7
TSL:1 MANE Select
c.1619-193C>T
intron
N/AENSP00000410833.2Q04446
GBE1
ENST00000895874.1
c.1613-193C>T
intron
N/AENSP00000565933.1
GBE1
ENST00000942742.1
c.1613-193C>T
intron
N/AENSP00000612801.1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43791
AN:
151688
Hom.:
6516
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.346
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.268
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43841
AN:
151806
Hom.:
6523
Cov.:
32
AF XY:
0.285
AC XY:
21138
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.346
AC:
14346
AN:
41438
American (AMR)
AF:
0.268
AC:
4072
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
541
AN:
3466
East Asian (EAS)
AF:
0.438
AC:
2246
AN:
5128
South Asian (SAS)
AF:
0.163
AC:
785
AN:
4824
European-Finnish (FIN)
AF:
0.232
AC:
2452
AN:
10566
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18540
AN:
67856
Other (OTH)
AF:
0.272
AC:
573
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1607
3214
4821
6428
8035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.275
Hom.:
26247
Bravo
AF:
0.298
Asia WGS
AF:
0.290
AC:
1008
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.2
DANN
Benign
0.58
PhyloP100
-0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2307058;
hg19: chr3-81586439;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.